+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand Type (Sativex, Epidiolex), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2023
  • Region: Global
  • Grand View Research
  • ID: 5534066
Description Jump to:

Quick Summary:

In the fast-paced, ever-evolving ecosystem of global healthcare, the emerging cannabis pharmaceuticals market is poised for a significant surge. This growth, fueled by accelerated adoption of cannabis for diverse indications such as pain, inflammation, sleep disorders, anorexia, epilepsy, schizophrenia, and multiple sclerosis, paves the path for new opportunities and avenues in the sector. A notable trend is the shift from cannabis herbal preparations to processed, quantified, and packaged prescription drugs, which is escalating the demand for cannabis-infused pharmaceutical products. Increased acceptance from consumers coupled with enhanced regulatory consent is further amplifying the market prospects.

In-depth research activities and clinical trials focusing on the therapeutic merits of cannabis underpin the market progression. For instance, cannabis products have shown potential in mitigating the adverse effects of chemotherapy in cancer patients. Likewise, an escalating number of physicians are discovering the advantages of cannabis as a medical alternative, equipping the patient with an additional treatment option. Regulatory endorsements for cannabis products, such as Epidiolex and Sativex, are also instrumental in market expansion, by advancing patient and physician perspectives.

Undoubtedly, the bright prospects of cannabis use in healthcare shape the future of the cannabis pharmaceuticals market, leading to a positive ripple effect across the larger pharmaceutical industry. Exclusive insights into this dynamic market await you in this detailed report.

The global cannabis pharmaceuticals market size is expected to reach USD 102.4 billion by 2030. The market is expected to expand at a CAGR of 62.5% from 2023 to 2030. Rapid growth in applications of cannabis for various indications including pain, inflammation, sleep disorders, anorexia, epilepsy, schizophrenia, and multiple sclerosis is estimated to driving cannabis pharmaceuticals market growth. There is a shift from cannabis herbal preparations to prescription drugs. Demand for processed, quantified, and packaged cannabis products is significantly increasing. Moreover, consumer as well as regulatory acceptance of cannabis products is increasing which in turn is positively impacting the market growth. Regulatory acceptance of cannabis products such as Sativex and Epidiolex are improving patient and physician perspective on cannabis as these drugs are developed and regulated by stringent process.

Increasing number of research and development activities and clinical trials for studying the therapeutic benefits of cannabis will drive the market growth during the forecast period. For instance, in September 2020, Tilray Inc. announced that its cannabis products are showing promising results in reducing vomiting and nausea in patients undergoing chemotherapy for cancer. According to the study, quarter of the patients consuming medical cannabis did not show nausea and vomiting. Such research studies are estimated to increase demand for cannabis in the pharmaceutical industry.

There is a rise in number of physicians prescribing cannabis to its patients due to increasing clinical evidence, growing awareness, and increasing number of patients looking for cannabis as a medical alternative. For instance, according to a survey published in 2019, 22% of the consumers were looking for replacing prescription or OTC drugs with CBD. Moreover, 30% took CBD in addition to the prescribed drug. Forty-seven percent replaced an OTC drug with CBD, 36% with prescription opioid, 33% with prescription anxiety drugs, and 22% with prescription sleep drug. Thus, increasing cannabis consumption will drive the pharmaceutical cannabis market globally.

Regulatory approval of cannabis is a major parameter supporting market growth. For instance, in November 2018, GW Pharmaceuticals, plc launched EPIDIOLEX (CBD) oral solution for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. EPIDIOLEX was approved by the FDA in June 2018. It is the first prescription pharmaceutical formulation plant-derived CBD and an antiepileptic drug.

Cannabis Pharmaceuticals Market Report Highlights

  • Epidiolex brand type emerged as the leading segment in 2022, with a revenue share of 97.5% in the global market, where as other brands segment is expected to witness fastest CAGR during the forecast period
  • Amongst all the regions, Europe accounted for the largest revenue share of 43.9% in 2022, whereas Middle East and Africa is projected to expand at the fastest CAGR during the forecast period
  • Jazz Pharmaceuticals (formerly, GW Pharmaceuticals, Inc.), is the leading player in the market. The company holds a majority share of the market and is expected to maintain its dominance in the next 3-4 years. However, with the launch of cannabis pharmaceuticals by other players. The share is expected to reduce over the forecast period.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Cannabis Pharmaceuticals Market Outlook
2.2 Global Cannabis Pharmaceuticals Market Segment Outlook
2.3 Global Cannabis Pharmaceuticals Market Competitive Insight
2.4 Global Cannabis Pharmaceuticals Snapshot
Chapter 3 Global Cannabis Pharmaceuticals Market Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Penetration & Growth Prospects Mapping
3.4 Global Cannabis Pharmaceuticals Regulatory Scenario
3.5 Cannabis Pharmaceuticals - PESTEL Analysis
3.5.1. Political
3.5.2. Environmental
3.5.3 Social
3.5.4 Technology
3.5.5. Legal
3.5.6 Economic
3.6 Cannabis Pharmaceuticals - Porter’s Analysis
3.6.1. Threat of New Entrants
3.6.2 Bargaining Power of Buyers
3.6.3 Competitive Rivalry
3.6.4 Bargaining Power of Suppliers
3.6. 5 Threat of Substitutes
3.7 Opportunity Analysis (2018 - 2022 - 2030)
3.8 Product Pipeline Analysis, By Stage
3.9 Key Deals and Strategic Alliances
3.10 Synthetic Cannabis Pharmaceuticals Overview
Chapter 4 Global Cannabis Pharmaceuticals Market: Brand Type Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Cannabis Pharmaceuticals Market: Brand Type Market Share Analysis, 2022 and 2030
4.3 Sativex
4.3.1 Sativex market estimates and forecasts, 2018 - 2030 (USD Million)
4.4 Epidiolex
4.4.1 Epidiolex market estimates and forecasts, 2018 - 2030 (USD Million)
4.5 Other Brands
4.5.1 Other Brands market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5 Global Cannabis Pharmaceuticals Market: Regional Estimates & Trend Analysis, By Brand Type
5.1 Global Cannabis Pharmaceuticals Market: Regional Movement Analysis
5.2 North America
5.2.1 North America cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.2.2 U.S.
5.2.2.1 U.S. cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.2.3 Canada
5.2.3.1 Canada cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3 Europe
5.3.1 Europe cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.2 U.K.
5.3.2.1 U.K. cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.3 Germany
5.3.3.1 Germany cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.4 Italy
5.3.4.1 Italy cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.5 France
5.3.5.1 France cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.6 Netherland
5.3.6.1 Netherland cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.7 Poland
5.3.7.1 Poland cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.8 Croatia
5.3.8.1 Croatia cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.9 Czech Republic
5.3.9.1 Czech Republic cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.3.10 Switzerland
5.3.10.1 Switzerland cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.4 Asia Pacific
5.4.1 Asia Pacific cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.4.2 Japan
5.4.2.1 Japan cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.4.3 South Korea
5.4.3.1 South Korea cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.4.4 Australia
5.4.4.1 Australia cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.4.5 New Zealand
5.4.5.1 New Zealand cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5 Latin America
5.5.1 Latin America cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.2 Brazil
5.5.2.1 Brazil cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.3 Mexico
5.5.3.1 Mexico cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.4 Argentina
5.5.4.1 Argentina cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.5 Columbia
5.5.5.1 Columbia cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.6 Uruguay
5.5.6.1 Uruguay cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.7 Chile
5.5.7.1 Chile cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.5.8 Peru
5.5.8.1 Peru cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.6 MEA
5.6.1 MEA cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
5.6.2 Israel
5.6.2.1 Israel cannabis pharmaceuticals market estimates and forecasts, by brand type, 2018 - 2030 (USD million)
Chapter 6 Global Cannabis Pharmaceuticals Market: Competitive Analysis
6.1 Company Market Position Analysis
6.2 List of Key Emerging Players and Market Differentiators
6.3 Company Categorization
6.4 Brand Share Analysis, 2018 - 2022
Chapter 7 Competitive Landscape
7.1 GW Pharmaceuticals
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 AbbVie Inc.
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Valeant Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Insys Therapeutics, Inc.
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 3 U.S. cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 4 Canada cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 5 Europe cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 6 U.K. cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 7 Germany cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 8 Italy cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 9 France cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 10 Netherland cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 11 Poland cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 12 Croatia cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 13 Czech Republic cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 14 Switzerland cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 15 Asia Pacific cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 16 Japan cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 17 South Korea cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 18 Australia cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 19 New Zealand cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 20 Latin America cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 21 Brazil cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 22 Mexico cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 23 Argentina cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 24 Columbia cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 25 Uruguay cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 26 Peru cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 27 Chile cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 28 MEA cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
Table 29 Israel cannabis pharmaceuticals market, by brand type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cannabis pharmaceuticals market snapshot, 2022 (USD Million)
Fig. 9 Cannabis pharmaceuticals market segmentation
Fig. 10 Cannabis pharmaceuticals market dynamics
Fig. 11 Cannabis pharmaceuticals market driver impact
Fig. 12 Cannabis pharmaceuticals market restraints impact
Fig. 13 Penetration & growth prospects mapping for cannabis pharmaceuticals market
Fig. 14 Cannabis Pharmaceuticals - PESTL Analysis
Fig. 15 Cannabis Pharmaceuticals - PORTER’s Analysis
Fig. 16 Opportunity analysis (USD Million)
Fig. 17 Cannabis Pharmaceuticals market, brand outlook: Key takeaways
Fig. 18 North America cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 U.S. cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Canada cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Europe cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 U.K. cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Germany cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 France cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig 25 Italy cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Netherlands cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Poland cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Croatia cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Switzerland cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Czech Republic cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Asia Pacific cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Japan cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 South Korea cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Australia cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 New Zealand cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Brazil cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Mexico cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Argentina cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Colombia cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Uruguay cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Chile cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Peru cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Israel cannabis pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • GW Pharmaceuticals
  • AbbVie Inc.
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Cannabis: The Medicinal Use - Product Image

Cannabis: The Medicinal Use

  • Report
  • Global
From
Prescription Drugs: Global Strategic Business Report - Product Image

Prescription Drugs: Global Strategic Business Report

  • Report
  • 150 Pages
  • Global
From
Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 120 Pages
  • Global
From
Analgesics Global Market Report 2023 - Product Image

Analgesics Global Market Report 2023

  • Report
  • 175 Pages
  • Global
From
Pharmaceutical Drugs Global Market Report 2023 - Product Image

Pharmaceutical Drugs Global Market Report 2023

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2023 Research and Markets. All Rights Reserved.